ELUTIA INC.
SILVER SPRING, MD · Founded 2015 · CIK 0001708527 · Medtech · Public
Drug-eluting biomaterial platforms for implantable medical devices
elutia.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $55M
- 6 Form D · Oct 2023
- 36 months since last filing
- Contracts
- $472K
- 13 awards · Veterans Affairs, Defense
- #386 of 4531 in medtech
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Implant | $15,125 | |
| Private capital raised | Form D · SEC | $12,000,000 | |
| Federal contract | Department of Veterans Affairs · Implant | $9,125 | |
| Federal contract | Department of Veterans Affairs · Putty | $12,000 | |
| Federal contract | Department of Veterans Affairs · Implant | $9,125 | |
| Federal contract | Department of Veterans Affairs · Placental Membrane | $3,640 | |
| Federal contract | Department of Veterans Affairs · Express Report: Cormatrix | $4,557 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Federal contract | Department of Defense · Vibone Cellular Allograft | $150,000 | |
| Federal contract | Department of Defense · Vibone Cellular Allograft | $100,000 | |
| Federal contract | Department of Defense · Vibone Cellular Allograft | $98,800 | |
| Federal contract | Department of Defense · Vibone Cellular Allograft | $44,800 | |
| Federal contract | Department of Defense · Vibone Cellular Allograft | $25,000 | |
| Private capital raised | Form D · SEC | $3,050,230 | |
| Private capital raised | Form D · SEC | $5,039,427 | |
| Private capital raised | Form D · SEC | $13,999,975 | |
| Private capital raised | Form D · SEC | $10,500,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 383 | KLAR SCIENTIFIC, INC. | $492K | $120K |
| 384 | ENCISION INC | $485K | $3.4M |
| 385 | Cayuga Biotech | $483K | — |
| 386 | ELUTIA INC. | $472K | $55M |
| 387 | INTELLIGENT PROSTHETIC SYSTEMS, LLC | $460K | — |
| 388 | CIRCADIAN POSITIONING SYSTEMS INC | $457K | — |
| 389 | DIAGNOSTIC BIOCHIPS, INC | $456K | $1.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David ColpmanDirector
- Lode DebrabandereDirector · Executive Officer
- Matthew FergusonExecutive Officer
- Jeffrey HametExecutive Officer
- Steven HochbergDirector
- William HochbergDirector
- Steven HotchbergDirector
- Maybelle JordanDirector
- Ronald LloydDirector · Executive Officer
- Brigid MakesDirector
- C. MillsDirector · Executive Officer
- Charles MillsDirector
- C. Mills. Ph.D.Director
- Kevin RakinDirector
- Michelle WilliamsExecutive Officer
- W. ZugaDirector
- William ZugaDirector
Patents
- Placental Tissue Compositions And Methodsgranted
- Enzymatic Treatment Of Tissues Intended For Implantationapplication
- Enzymatic Treatment Of Tissues Intended For Implantationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.